Screening everyone 35 and older for chronic kidney disease would save lives
Many people don’t know they have chronic kidney disease until it progresses. A new study by Stanford Medicine researchers finds that screening would increase life expectancy in a cost-effective way.
William Robinson, who made fundamental hepatitis B discoveries, dies at 89
Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.
News & Research
One-and-done COVID-19 drug successful
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
REACH Initiative to expand equity, diversity
The Stanford School of Medicine launched the REACH Initiative to boost representation in medicine and reduce health inequities among minority populations.
Celiac expert Gary Gray dies at 89
Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.
Race linked to child abuse reports
Over-reporting of Black children and under-reporting of white children as suspected abuse victims suggests systemic bias from medical providers, Stanford Medicine research shows.
ARPA-H director shares agency’s vision
Renee Wegrzyn, who leads the Advanced Research Projects Agency for Health, discussed the agency’s plan to accelerate better health outcomes for everyone.
Fasting causes liver cell division
Cells in the adult liver were thought to divide rarely. But a study led by Stanford Medicine researchers found intermittent fasting causes rapid cell division.
Pain treatment inspired by chickens
In a mouse study led by Stanford Medicine scientists, a drug made mammalian pain receptors more like those in birds — and more resistant to some forms of pain.
Telomere length crucial in muscular dystrophy
Telomeres shorten in heart muscle cells from people with Duchenne muscular dystrophy. A Stanford Medicine study finds blocking this process improves the health of these cells grown in a dish.
Diabetes drug may treat heart disease
A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.
Immune cells become cancer killers
Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.
Stanford Medicine on social determinants of health
The new issue of Stanford Medicine magazine features articles about the ways nonmedical factors can help or hinder our health and presents initiatives to promote health equity.
Diabetes expert training program
Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.
How social factors make or break us
Stanford Medicine's blog about health, medicine, science & innovators
and Regenerative Medicine
Researchers expand human blood stem cells
For decades, researchers have been trying to expand human blood stem cells in culture. Researchers at the institute have recently accomplished this, opening the way to explore many new medical therapies and avenues of basic research.
Centering mothers and families in the care of low-weight infants
New WHO resources underscore the life-saving value of kangaroo mother care and provide a roadmap for making it available to mothers and babies around the world.
To study aging, researchers give killifish the CRISPR treatment
A new study demonstrating CRISPR gene editing in killifish opens the doors for ambitious research on the biological drivers of aging.
- – Stanford Report
Thirteen faculty elected to American Academy of Arts and Sciences
Faculty from across disciplines were honored by the American Academy of Arts and Sciences, recognizing work that advances the common good.
- – Institute for Stem Cell Biology
and Regenerative Medicine
Limiting clonal expansion
Researchers find an inherited genetic variant that is key in slowing the expansion of blood cell clones.
is focused on serving our community with courage, compassion, and innovation. Comprised of Stanford Children’s Health, Stanford School of Medicine, and Stanford Health Care, we’re bringing our collective strength in research, education, and clinical care to the fight against COVID-19 within the Bay Area and around the world.